Anuh Pharma Limited has submitted an investor presentation to the National Stock Exchange, marking a routine corporate disclosure. The filing aligns with standard regulatory requirements for listed entities.
Anuh Pharma Limited submitted an investor presentation to the NSE, notifying the exchange about the availability of the document for investor review.
Anuh Pharma Limited has submitted an investor presentation to the NSE, providing stakeholders with updated corporate and financial information.
Anuh Pharma Limited (NSE: ANUHPHR) has submitted its investor presentation to the National Stock Exchange, allowing stakeholders to review company information through the official filing system.
Anuh Pharma Limited has filed an investor presentation with the NSE, providing stakeholders with updated corporate information and strategic insights.
Anuh Pharma Limited has notified the NSE about an investor presentation, continuing its practice of shareholder communication through exchange filings.
Anuh Pharma (ANUHPHR) has released its Q4 FY 2025-26 investor presentation via BSE filing, giving shareholders and market participants insight into the company's latest business performance and outlook.
Anuh Pharma (ANUHPHR) has filed its Q4 FY 2025-26 investor presentation with BSE, giving stakeholders access to the latest quarterly performance overview and strategic outlook.
Anuh Pharma has released its Q4 FY 2025-26 investor presentation, providing stakeholders with a detailed overview of the company's recent performance and strategic positioning.
NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.
Need more? Pro tracks up to 500 companies with preferential issue alerts.
No credit card required. Connect WhatsApp or Telegram in minutes.